期刊文献+

UPLC-MS/MS测定beagle犬内西罗莫司血药浓度 被引量:2

Determination of sirolimus in whole blood of beagle dog by UPLC-MS/MS
下载PDF
导出
摘要 目的建立测定beagle犬内西罗莫司(SRL)血药浓度的UPLC-MS/MS联用方法。方法色谱柱为Agilent C18柱(50 mm×2.1 mm,1.7μm,);预柱为C18柱(4.0 mm×3.0 mm,5μm);流动相为乙腈-水(90∶10,v/v);流速为0.30 ml/min;柱温为50℃;进样室温度为4℃。离子源为ESI源;正离子方式检测;扫描方式为多反应监测(MRM);用于定量分析的离子反应分别为m/z 936.6→m/z 409.7(西罗莫司)和m/z 826.6→m/z 415.4(内标他克莫司)。取全血样品经液-液萃取后进样20μl。结果 SRL在0.50~12.00 ng/ml浓度范围内呈良好的线性(r=0.999 7),定量下限0.5 ng/ml,日内、日间精密度(RSD)均小于15%,方法回收率均大于90%,萃取回收率大于76%。结论本方法具有样品处理简单,方法灵敏、快速、选择性强,满足西罗莫司在beagle犬体内药物检测的要求。 Objective To develop a UPLC-MS/MS method for the determination of sirolimus in whole blood of beagle dog.Methods Sirolimus and internal standard Tacrolimus were extracted from whole blood with liquid-liquid extraction,then separated on a Agilent C18 column (50 mm × 2.1 mm, 1.7 μ m) at the flow-rate of 0.30 ml/min. The mobile phase was Acetonitrile-water (90: 10) and the column temperature was 50℃. Electrospray ionization (ESI) source was applied and operated in the positive ion mode. Multiple reaction monitoring ( MRM ) mode with the transitions of m/z 936.6→409.7 and m/z 826.6→415.4 were used to quantify sirolimus and the internal standard,respectively. Results The calibration linea range of blood-Sirolimu concentrations was 0.50 - 12.00 ng/ml( r = 0. 999 7). The low limit of quantification was 0.50 ng/ml . The intra-and inter-day precisions (RSDs) were less than 15 %. The method recoveries were more than 90% . The extraction recoveries were more than 76%. Conclusions The method was specific, sensitive,rapid and suitable for the pharmacokinetic study of sirolimus in whole blood of beagle dog.
出处 《药学实践杂志》 CAS 2011年第5期353-355,375,共4页 Journal of Pharmaceutical Practice
关键词 西罗莫司 超高效液相色谱-质谱联用 血药浓度 sirolimus UPLC-MS/MS whole blood
  • 相关文献

参考文献10

二级参考文献69

  • 1王征,樊嘉.雷帕霉素在器官移植中的研究进展[J].国外医学(移植与血液净化分册),2004,2(5):33-35. 被引量:5
  • 2李晓玉.免疫抑制剂的研究概述[J].药学服务与研究,2005,5(2):105-110. 被引量:19
  • 3祝仕清,牛长群,耿亚鹏.UPLC(超高效液相色谱)/MS/MS联用技术测定全血中的西罗莫司[J].中国抗生素杂志,2007,32(6):347-349. 被引量:9
  • 4HARDMAN J G, LIMBIRD L E. Goodman & Gilman'S Pharmacological Basis of Therapeutics(古德曼·吉德曼 治疗学的药理学基础) [M]. Tenth Edition Beljing: People's medical publishing House, 2002:1339. 被引量:1
  • 5VICENTE F B, SMITH F A, PENG Y,et al. Evaluatian of an immunoassay of whole blood sirolimus in pediatric transplant patients in comparison with high-performance liquid chromatugraphy/tandem mass spectrometry [ J ]. Clin Chem Lab Med, 2006,44 ( 4 ) :497 -499. 被引量:1
  • 6BORROWS R, CHUSNEY G, LOUCAIDOU M, et al. Tacrolimus monitoring in renal transplantation: a comparison between high- performance liquid chromatography and immunoassay [ J ] .Transplant Proc,2005,37(4) :1733-1735. 被引量:1
  • 7SALM P, TAYLOR P J, LYNCH S V, et al. A rapid HPLC-mass spectrometry cyclosporln method suitable for current monitoring practices [ J ]. Clin Biochem,2005,38 ( 7 ) :667-673. 被引量:1
  • 8RAYMOND G M. Immunosuppressant drag monitoring: is the labortary meeting clinical expections? [ J ]. Transplantation ,2005, 39(1) :119-127. 被引量:1
  • 9VIGNOT S, FAIVRE S, AGUIRRE D, et al. rnTOR-targeted therapy of caneer with rapamyein derivatives [ J ] . Ann Oncol, 2005, 16(4) :525-537. 被引量:1
  • 10YANEZ J A, FORREST M L, OHGAMI Y, et al. Pharmacometrics and delivery of novel nanoformulated PEG-b-poly ( ε- caprolactone) micelles of rapamycin [ J ] . Cancer Chemoth Pharm, 2008, 61(1) : 133-144. 被引量:1

共引文献42

同被引文献13

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部